ROIV - ADPT and CURV among pre-market gainers

2023-09-26 08:21:55 ET

• Gainers: Soleno Therapeutics ( SLNO ) +154% . announces positive statistically significant top-line results from randomized withdrawal period of study C602 of DCCR for prader-willi syndrome.
• Immunovant ( IMVT ) +64% announces positive initial IMVT-1402 phase 1 SAD and 300 mg subcutaneous MAD results .
• Pliant Therapeutics ( PLRX ) +27% announces positive safety and exploratory efficacy data from phase 2a INTEGRIS-PSC clinical trial of Bexotegrast in patients.
• Roivant Sciences Ltd ( ROIV ) +9% announces positive initial IMVT-1402 phase 1 SAD and 300 mg subcutaneous MAD results.
• Bullfrog AI Holdings ( BFRG ) +15% announces positive data from preclinical study evaluating Novel prodrug of Mebendazole for treatment of Glioblastoma.
• Adaptive Biotechnologies Corp ( ADPT ) +14% .
• Liberty Media ( LSXMA ) +11% proposes combination with Sirius XM .
• Torrid Holdings ( CURV ) +6% .

For further details see: